Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice?

Affiliations

• ¹ Post-graduation Program in Medicine, Precision Oncology & Health Economics Research Group (OncoPRECH), Faculty of Medicine, Nine of July University (UNINOVE), São Paulo, Brazil.
• ² Division of Medical Oncology/Oncotorax Group, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
• ³ Algarve Biomedical Centre, Department of Biomedical Sciences and Medicine, University of Algarve (UALG), Faro, Portugal.
• ⁴ Department of Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
• ⁵ Department of Biomedicine & I3S, Faculty of Medicine, University of Porto (FMUP), Porto, Portugal.
• ⁶ Hospital São José & Hospital São Joaquim-Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
• ⁷ Department of Radiotherapy/Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, University Hospital of Larisa, Biopolis, Greece.
• ⁸ Division of Thoracic Oncology, Mont Vernon Cancer Center, London, UK.